2024 annual financial data
Aspire Biopharma Holdings 2024 Operating margin
Aspire Biopharma Holdings 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,088,671 USD and net income was -12,537,000 USD.
Operating cash flow was -265,186 USD.
Get free Aspire Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,088,671 USD
- Net income
- -12,537,000 USD
- Operating cash flow
- -265,186 USD